Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human GRM2 Antibodies:
anti-Mouse (Murine) GRM2 Antibodies:
anti-Rat (Rattus) GRM2 Antibodies:
Go to our pre-filtered search.
Human Polyclonal GRM2 Primary Antibody for IHC, ELISA - ABIN1584809
Güntert, Hänggi, Othman, Suriyanarayanan, Sonda, Zuellig, Hornemann, Ogunshola: 1-Deoxysphingolipid-induced neurotoxicity involves N-methyl-d-aspartate receptor signaling. in Neuropharmacology 1970
Human Polyclonal GRM2 Primary Antibody for ELISA, IHC - ABIN4334107
So, Fong, Chen, Hui, Ng, Cherny, Mak, Cheung, Chan, Chen, Li, Sham: Identification of neuroglycan C and interacting partners as potential susceptibility genes for schizophrenia in a Southern Chinese population. in American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2009
The present data demonstrateD that a mechanism of group II mGluR (show GRM8 Antibodies)-induced analgesia identified in rodent sensory neurons translates mechanistically to human sensory neurons
this work offers new insights into the functioning of the mGlu2 receptor, which might contribute to the development of new and improved PAMs
Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia.
Study furthers our understanding of positive allosteric modulation of the mGlu2 receptor and can contribute to improved future design of mGlu2 modulators.
Findings suggest that mGluR2/3 and mGluR5s are unaltered in the anterior cingulate cortex in psychotic and nonpsychotic depression, bipolar disorder and schizophrenia
Results demonstrate no changes in expression and density of both 5-HT2AR and mGlu2/3R in the postmortem prefrontal cortex of subjects with major depressive disorder under basal conditions; antidepressant treatment induces a decrease in 5-HT2AR density
Human anterior cingulate cortex from alcoholic patients shows a significant reduction in mGluR(2) transcripts compared to control subjects
Three residues located at the intracellular end of transmembrane domain four are necessary for the mGlu2 receptor binding to 5TR2A.
the promoter methylation of the GMR2 and GMR5 genes greatly decreased the risk of schizophrenia, and the expression level of the GRM2, GRM5 (show GRM5 Antibodies), and GRIA3 (show GRIA3 Antibodies) genes increased significantly in patients in comparison to healthy controls.
the structural properties for the H8 domain of the mGluR2 receptor; H8 behaves as a sensor of cholesterol concentration.
mGlu2 activation exerts effects on striatal physiology that extend beyond modulation of corticostriatal synapses, and has the potential to influence cognition and striatum-related disorders via inhibition of thalamus-derived glutamate (show GRIN1 Antibodies) and dopamine release.
These studies provide a foundation for future research seeking to parse out the roles of mGlu2 from mGlu3 (show GRM3 Antibodies), paving the way for better understanding of how these receptors regulate activity in the brain.
provided evidence that JARID1B (show KDM5B Antibodies) via modulation of stemness-related signaling is a putative novel therapeutic target for treating malignant NB
Activation of GABA(B) or mGlu2/3 receptors inhibited both evoked presynaptic Ca(2 (show CA2 Antibodies)+) transients and striatal field potentials.
In GRM2 knockout mice motor coordination and cognition is unchanged compared to GRM2/3 double knockout mice.
The findings support the possibility that interactions between mGlu2/3 and dopamine may be relevant to the pathophysiology and therapy of schizophrenia and other disorders
mGluR3 (show GRM3 Antibodies) knockouts did not differ from controls in reinstatement of drug-seeking behavior, suggesting that mGluR2 receptors are critical in mediating addictive-like behavior.
In the central nervous system, mGluR2 and mGluR4 (show GRM4 Antibodies) form a hetero-complex with a distinct pharmacological profile.
The reduction in the expression of mGluR2 and mGluR3 (show GRM3 Antibodies) may be involved in the development of benzodiazepine dependence.
L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Two transcript variants encoding different isoforms have been found for this gene.
glutamate metabotropic receptor 2
, glutamate receptor homolog
, metabotropic glutamate receptor 2
, G protein coupled receptor, family C, group 1, member B
, G protein-coupled receptor, family C, group 1, member B